The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An Immune-metabolic signature (IMMETCOLS) identifies three clusters in mCRC with different immune-phenotype distribution and potential clinical implications.
 
Ivan Archilla
No Relationships to Disclose
 
Leire Pedrosa
No Relationships to Disclose
 
Marta Garcia de Herreros
No Relationships to Disclose
 
Laia Fernandez-Mañas
No Relationships to Disclose
 
Francis Esposito
No Relationships to Disclose
 
Pedro Jares
No Relationships to Disclose
 
Carolina Figueras
No Relationships to Disclose
 
Sandra López
No Relationships to Disclose
 
Helena Oliveres
Research Funding - Amgen; Biocartis; Incyte; Merck; NanoString Technologies; Roche
Travel, Accommodations, Expenses - Advanced Medical Diagnostics; AstraZeneca Spain; Bayer; Cancer Expert Now; fundacion clinica Universitaria; Pierre Fabre; Roche; Sanofi; SERVIER; Shire; Sirtex Medical
 
Carles Foguet
Patents, Royalties, Other Intellectual Property - My Institution (Universitat de Barcelona) is applying fora patent (INFORMATIVE TRANSCRIPTOMIC SIGNATURE [IMMETCOLS] TO PREDICT CHECK POINT INHIBITOR EFFICACY) where I am listed as one of the inventors. (Inst)
 
Marta Cascante
Patents, Royalties, Other Intellectual Property - Patent on a Transcriptomic Signature (IMMETCOLS) to stratify solid tumors and predict response to checkpoint inhibitor efficacy (Maurel J, Cascante M et al, 20-09-2021-application-EP21382772) (Inst)
 
Joan Maurel
Consulting or Advisory Role - AstraZeneca; Pierre Fabre; Sanofi; Servier; Shire; Sirtex Medical
Research Funding - Amgen; Biocartis; Biocartis; Incyte; Merck Serono; NanoString Technologies; Roche
Travel, Accommodations, Expenses - Amgen
Other Relationship - Advance Medical/Teladoc Health; AstraZeneca; Bayer; Cancer Expert Now; Fundación Clínica Universitaria; Pierre Fabre; Roche; Sanofi Pasteur; SERVIER; Shire; Sirtex Medical
 
Miriam Cuatrecasas
No Relationships to Disclose